+11%

est. 2Y upside i

HealthcareSeries D+

Connecting stakeholders across the healthcare ecosystem.

Rank

#1799

Sector

Healthcare

Est. Liquidity

~3Y

Data Quality

Data: Low

H1 offers a potentially attractive but highly uncertain equity opportunity due to missing revenue data.

Last updated: July 21, 2026

Bull (25%)+55%

IPO window or category leadership maintains a 10x revenue multiple. Projected $120M revenue in 24 months implies $1.2B exit, a 55% enterprise upside, though common stock faces preference overhang.

Base (55%)+9%

Multiple converges to public comp midpoint of 7x. $120M revenue yields $840M exit, a 9% enterprise upside. Profitable operations and recent CVS investment support stability.

Bear (20%)-38%

Multiple compresses to 4x due to incumbent competition or slowing growth. $120M revenue yields $480M exit, below total funding of $361M, leaving common stock with minimal recovery (enterprise -38% implies common near -100% after preference).

Est. time to liquidity~3.0 years

Preference Stack Risk

severe

Funding Intensity

47%

Total funding of $361M represents 46.7% of the $773M valuation, creating a severe preference overhang that will significantly dilute common equity in any exit below ~$1.13B.

Dilution Risk

low

The company is profitable and recently raised $40M, reducing the likelihood of a dilutive raise within 24 months.

Secondary Liquidity

none

No secondary market or tender offer data is available; employee shares are likely illiquid until an IPO or acquisition.

Questions to Ask at the Interview

Strategic questions based on H1's data — designed to show you've done your homework.

  • 1

    “How does H1 differentiate from IQVIA's and Salesforce's healthcare data platforms in terms of data coverage and AI capabilities?”

  • 2

    “What is the current annual recurring revenue (ARR) and net revenue retention rate, especially among top pharma customers?”

  • 3

    “Given the recent $40M round and profitability, what is the expected timeline to a liquidity event and how does the cap table structure affect employee equity?”

Community

Valuation Sentiment

Our model estimates +11% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.